BR0009607A - Pope method to quantify growth transformation bi-factor and method to detect cancer using the same technique - Google Patents

Pope method to quantify growth transformation bi-factor and method to detect cancer using the same technique

Info

Publication number
BR0009607A
BR0009607A BR0009607-5A BR0009607A BR0009607A BR 0009607 A BR0009607 A BR 0009607A BR 0009607 A BR0009607 A BR 0009607A BR 0009607 A BR0009607 A BR 0009607A
Authority
BR
Brazil
Prior art keywords
factor
same technique
pope
detect cancer
growth transformation
Prior art date
Application number
BR0009607-5A
Other languages
Portuguese (pt)
Inventor
Seung Won Jin
Hoon Shin
Chang Gi Lim
Original Assignee
Hanmi Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd
Publication of BR0009607A publication Critical patent/BR0009607A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/495—Transforming growth factor [TGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"MéTODO PARA QUANTIFICAR O FATOR-<225>1 DE TRANSFORMAçãO DE CRESCIMENTO E MéTODO PARA DETECTAR CâNCER UTILIZANDO A MESMA TéCNICA". A quantidade de TGF-<225>-1 em uma amostra é medida tratando a amostra com um receptor específico para TGF-<225>-1 para formar um complexo entre TGF-<225>-1 e o receptor e medindo a quantidade do complexo."METHOD FOR QUANTIFYING THE GROWTH TRANSFORMATION FACTOR- <225> 1 AND METHOD FOR DETECTING CANCER USING THE SAME TECHNIQUE". The amount of TGF- <225> -1 in a sample is measured by treating the sample with a specific receptor for TGF- <225> -1 to form a complex between TGF- <225> -1 and the receptor and measuring the amount of complex.

BR0009607-5A 1999-04-09 2000-04-10 Pope method to quantify growth transformation bi-factor and method to detect cancer using the same technique BR0009607A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR19990012568 1999-04-09
KR19990043935 1999-10-12
PCT/KR2000/000329 WO2000062062A1 (en) 1999-04-09 2000-04-10 METHOD FOR QUANTIFYING TRANSFORMING GROWTH FACTOR-β1 AND METHOD FOR DETECTING CANCER BY USING SAME

Publications (1)

Publication Number Publication Date
BR0009607A true BR0009607A (en) 2002-01-08

Family

ID=26634921

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0009607-5A BR0009607A (en) 1999-04-09 2000-04-10 Pope method to quantify growth transformation bi-factor and method to detect cancer using the same technique

Country Status (11)

Country Link
EP (1) EP1166112A4 (en)
JP (1) JP2002541479A (en)
CN (1) CN1355882A (en)
AU (1) AU768029B2 (en)
BR (1) BR0009607A (en)
CA (1) CA2369892A1 (en)
ID (1) ID30316A (en)
MX (1) MXPA01009942A (en)
NZ (1) NZ514596A (en)
TR (1) TR200102917T2 (en)
WO (1) WO2000062062A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03004675A (en) * 2000-11-28 2003-09-05 Amgen Inc Transforming growth factor-beta-related molecules and uses thereof.
JP4834835B2 (en) * 2006-07-27 2011-12-14 国立大学法人浜松医科大学 Diagnostic agent for autism

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59195162A (en) * 1983-04-21 1984-11-06 Toyo Jozo Co Ltd Reagent for assay of transforming gross factor
JPS59216058A (en) * 1983-05-23 1984-12-06 Toyo Jozo Co Ltd Determining method of transforming gross factor
JPS59226864A (en) * 1983-06-07 1984-12-20 Toyo Jozo Co Ltd Method for measuring enzyme immune of transforming gross factor
JPS6018764A (en) * 1983-07-12 1985-01-30 Toyo Jozo Co Ltd Immunological measurement of transforming growth factor
JPH02126157A (en) * 1988-11-04 1990-05-15 Tosoh Corp Method for immunologically measuring human transforming growth factor-beta
WO1993010215A1 (en) * 1991-11-15 1993-05-27 Memorial Sloan-Kettering Cancer Center Purified proteoglycan betaglycan, compositions, and methods
GB9601081D0 (en) * 1995-10-06 1996-03-20 Cambridge Antibody Tech Specific binding members for human transforming growth factor beta;materials and methods

Also Published As

Publication number Publication date
JP2002541479A (en) 2002-12-03
ID30316A (en) 2001-11-22
CA2369892A1 (en) 2000-10-19
AU4147100A (en) 2000-11-14
TR200102917T2 (en) 2002-03-21
WO2000062062A1 (en) 2000-10-19
EP1166112A1 (en) 2002-01-02
EP1166112A4 (en) 2004-11-10
CN1355882A (en) 2002-06-26
MXPA01009942A (en) 2003-07-14
AU768029B2 (en) 2003-11-27
NZ514596A (en) 2003-03-28

Similar Documents

Publication Publication Date Title
DE69842017D1 (en) PROCEDURE FOR EARLY DETECTION OF DISEASES
BR9814446A (en) Viscosity measuring apparatus and method of use
DK1067384T3 (en) Sample detection to initiate the time measurement in an electrochemical test
ES2192269T3 (en) APPARATUS FOR THE HIGHLY SENSITIVE MAGNETIC DETECTION OF ANALYTES.
NO20020549L (en) Drilling system for continuous well drilling with stationary sensor measurements
EP1245192A4 (en) Biological photometric device
ATE270522T1 (en) DEVICE FOR DETECTING PLAQUE USING FLUORESCENCE MEASUREMENT
DE60022042D1 (en) THIENO AND FUROPYRIMIDINE DERIVATIVES AS A2A RECEPTOR ANTAGONISTS
DE69931520D1 (en) ARRANGEMENT FOR MEASURING THE THICKNESS OF A TISSUE
NZ515311A (en) Mass screening and highly specific early identification of colorectal or metastatic breast cancer by measuring TIMP-1 tissue inhibitor
ES2077909T3 (en) METHOD TO DETECT AN INFLAMMATION.
MX9606218A (en) Flt4 receptor tyrosine kinase and its use in diagnosis and therapy.
ATE279531T1 (en) TEST TO DETECT THE ACTIVITY OF PHOSPHO-N-ACETYLMURAMYL PENTAPEPTIDE TRANSLOCASE
DE60124975D1 (en) AUTOMATIC APPARATUS TO MEASURE WATER TOXICITY
ES2531368T3 (en) Methods and kits to diagnose tumorigenicity and determine resistance to the antineoplastic effects of antiestrogen therapy
ATE240522T1 (en) CHEMILUMINESCENCE IMMUNOASSAY FOR DETECTION OF AN ANALYTE RELATED TO CHAGAS DISEASE IN A SAMPLE
BR0009607A (en) Pope method to quantify growth transformation bi-factor and method to detect cancer using the same technique
DE59905904D1 (en) Device for measuring properties of a longitudinally moving test specimen
BR0314638A (en) Measurement equipment for measuring dentures and diameters in dynamically balanced components
EP1247061A4 (en) Magnetic tip for tape measure and method of use
CN213657682U (en) Management detection feeler gauge convenient for analyzing different crack gaps of building
DE69736893D1 (en) OXYDATIVE METABOLISM IN SMOOTH MUSCLE CELLS: METHODS RELATED TO THEM
CN210862691U (en) Building engineering quality detection equipment
DK1320736T3 (en) Handrail tester
DE60031963D1 (en) EVIDENCE OF A MSRV-1 INDUCED SUPERANTIGENACTIVITY IN A BIOLOGICAL SAMPLE

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 8A, 9A E 10A ANUIDAD(S).

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2073 DE 28/09/2010.